The global 3D bioprinting market size is expected to reach USD 5.3 billion by 2030, expanding at a CAGR of 12.5% over the forecast period, according to a new report by Grand View Research, Inc. Rising cases of COVID-19 and high prevalence of chronic diseases are some of the major factors contributing to the growth. During the outbreak of the pandemic, 3D printing has stepped up to become a vital technology to support improved healthcare and emergency response.
The COVID-19 epidemic, since it was first identified in China in December 2019. Until January 12, 2021, more than 91.5 million cases of COVID-19 were reported globally, with more than 1,956,880 deaths, across the globe. This pandemic has fast-tracked the development of vaccine and drug testing.
3D Bioprinting Market Report Highlights
- The medical segment accounted for the largest share of 37.6% in 2022 due to the increasing investment made in R&D
- The magnetic levitation segment is anticipated to witness the highest CAGR of 13.7% over the forecast period due to technological development, and increasing adoption of magnetic levitation techniques by various innovators
- North America dominated the market in 2022 with a share of 30.9%. Growing government expenditure on the healthcare industry is one of the major factors driving the market in this region
- Some of the key players include Organovo; Envision TEC; Inventia Life Science PTY LTD; Poietis; Vivax Bio, LLC; Allevi; Cyfuse Biomedical K.K.; 3D Bioprinting Solutions; Cellink Global; Regemat 3D S.L.
For More Details or Sample Copy please visit link @: 3D Bioprinting Market Report
In the meantime, various 3D bioprinting companies are focused on the R&D of artificial tissues. With the help of U-FAB and other bioprinting technologies, CLECELL company has created respiratory epithelium artificial tissue which will help to prevent infection and tissue injury through the use of the mucociliary elevator.
The pandemic not only affected the well-being of people, but also affected the economy, and various other healthcare infrastructures worldwide. It severely disrupted the medical devices and pharmaceutical supply chains across the world. In such critical situations, various 3D bioprinting companies have created a global movement to supply emergency medical equipment such as ventilators, and personal protection equipment (PPE), to healthcare workers.
North America held the highest share of about 30.9% in 2022. Increasing adoption of 3D bioprinting for the production of medical products is expected to be one of the major factors contributing to market growth in this region. Whereas, Asia Pacific is anticipated to witness increased technological development in the pharmaceutical and biopharmaceutical sectors.
Gain deeper insights on the market and receive your free copy with TOC now @: https://www.grandviewresearch.com/industry-analysis/3d-bioprinting-market
We have segmented the global 3D bioprinting market based on technology, application, and region.
Research Methodology
We employ a comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecasts possible. We utilize a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our market estimates and forecasts are derived through simulation models. A unique model is created and customized for each study. Gathered information for market dynamics, technology landscape, application development, and pricing trends are fed into the model and analyzed simultaneously.
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S. based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Contact:
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll-Free: 1-888-202-9519
Email: [email protected]
Web: https://www.grandviewresearch.com
The study involved four major activities in estimating the current size of the regenerative medicine market.
Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market.
The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.
Both top-down and bottom-up approaches were employed to estimate the complete market size.Major Growth Boosting Factors: Growth in Regenerative Medicine Market is largely driven by the rising prevalence of chronic diseases, genetic disorders, and cancer; rising investments in regenerative medicine research; and the growing pipeline of regenerative medicine products.Revenue Growth Opportunities: The Global Regenerative Medicine Market is expected to reach USD 17.9 billion by 2025 from USD 8.5 billion in 2020, at a CAGR of 15.9%.Recent Developments:# In February 2020, Integra Lifesciences (US) launched AmnioExcel Plus Placental allograft membrane.# In November 2019, Stryker Corporation (US) acquired Wright Medical (US) to strengthen its product portfolio.# In March 2019, Smith & Nephew (UK) acquired Osiris Therapeutics (US) to strengthen its product portfolio.Growth Opportunity: Implementation of the 21st Century Cures Act;The 21st Century Cures Act was signed into law in the US in December 2016.
Among other objectives, this new law has been enacted to advance regenerative medicine research and medical innovation and covers various provisions that may impact the development and approval of several products in the coming years.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=65442579Based on products,The regenerative medicine market is segmented into tissue-engineered products, cell therapies, gene therapies, and progenitor and stem cell therapies.
The tissue-engineered products segment accounted for the largest share in the market in 2019.
Biomaterials 2021 conference which will be held on September 29-30, 2021 at Edinburgh, Scotland offers the platform with its organized scientific program to the audience, which comprises of keynote lectures, plenary talks, interactive panel discussions, and poster sessions on the subjects like properties of Biomaterials and Applications, Biomaterials and Nanotechnology, Tissue Engineering, Bio-imaging & Biophotonics, 3D printing of Biomaterials, Biomaterials in Delivery systems, Functional Nanomaterials, Nanoscience and Nanomaterials Applications.The conference is the promotion of an educational program on biomaterials.
By organizing a variety of events, workshops, and exhibition during the conference, offering multiple opportunities for participants to receive mentoring and advice and gather scientific contacts, we aim to increase the active participation of younger members of this global population and bestow several awards upon young researchers and students.The mission of the conference is by organizing a variety of events, workshops, and exhibition during the conference, offering multiple platforms for participants to receive mentoring, advice and gather scientific contacts, we aim to increase the active participation of young researchers of this global population and confer several awards upon students and young members.The main emphasis of the conference is to send each person, home with a head full of knowledge, a heart full of memories and friendships that will last for years.
The Conference will be addressing the theme Unveiling Novel Trends in Material Science Technology.Targeted Audience:Biomedical Business Entrepreneurs3D Printing companiesBiomedical Engineering, Materials science, and Nano Science ScientistsBiomaterials ResearchersTissue Engineering ResearchersNanotechnology ResearchersBiomedical Engineering, Materials Science and Nano Science Faculty members, students, Associations and SocietiesNanomaterials ResearchersMedical device manufacturing companies and doctors Why Should I Attend?Biomaterials 2021 Conference helps the Academia and Industry to develop through discussion on innovative research methods in Biomaterials Science and Nanotechnology.The conference gives an opportunity for meeting with Biomaterial and Nanomaterial Companies, Academic speakers, Industrial experts, interacting and defining novel prospects in business.
It is the added value to biomedical, pharmaceutical and R businesses.
Novel approaches and applications about biomaterials like the gene/drug delivery systems development and industrializing insights & gain the latest technologies about novel biomaterials and biomaterials companies.For more information Visit: https://biomaterials.alliedacademies.com/
UAE’s health care system is all set to undergo a significant transformation in the global market.
It is predicted that in the next five years, UAE’s health care sector will grow by a compound annual growth rate (CAGR) of 75%.
Medical tourism is also expected to get a massive thrust.The emerging trend of spending in private healthcare facilities and inclination towards preventive care owing to a robust healthcare system and health consciousness have propelled the revenue generated in recent years.
A whopping response to the state-of-the-art system with modern care facilities followed.
The rise in lifestyle diseases and increased awareness for precaution and treatment have led to the demand for excellence in healthcare, and medical establishments are only ready to oblige.The UAE has also been quick to adopt technologies in healthcare services that have become the need of time for fast and efficient deliverance.
For instance, telehealth that had been trending pre-Covid got a significant impetus during Covid.
